In Focus.

Early cancer detection by plasma CTCF transcription factor analysis

Genomeweb to Host Volition Webinar on Neutrophils

Volition Business Review 2023

Nu.Q® NETs: New sepsis study at Guy's & St Thomas NHS Foundation Trust

Nu.Q® Discover White Paper: The epigenetic keys to unlocking the full potential of immunotherapy

London Vet Show 2023: highlights

Meet Marielle Herzog, our R&D Director

Meet Remi Rabeuf, our Life Cycle Leader

Scientific Advisory Board Update

Volition's collaboration with Professor Lea Payen and Hospices Civils de Lyon

Scaling Up for Success: Volition Partners with IVD Research for US Manufacturing

Meet Ben Berman

Genomeweb to Host Volition Webinar on EZH2 Inhibitors

Celebrating International Day of Women and Girls in Science

Meet Gaetan Michel

Volition Business Review 2022

What's on: January 2023

Volition and Oncovet collaboration: interview with Dr. Jérôme Benoit

Our Scientific Advisory Board meeting 2022

Learn about NETs, NETosis and Nu.Q® NETs

A spotlight on... Volition's Asia Strategy

October Roundup

A spotlight on...Volition's Commercialisation Strategy

A spotlight on... Volition's U.S. Clinical Product Strategy

August Roundup

What's on in July

Volition to Host Second Genomeweb Webinar

Volition Opens New Innovation Hub

Epigenetic cancer tests for both ends of the leash

Volition presents at EuroMedLab 2022

Meet Tom Butera

Volition Hosts Genomeweb Webinar

Meet Terry Kelly

Volition Business Review 2021